Medicarecard.com MedicareCard Replacement Genetic abnormality predicts benefit from treatment for a rare brain tumor

Genetic abnormality predicts benefit from treatment for a rare brain tumor

A clinical trial has shown that addition of chemotherapy to radiation therapy leads to a near doubling of median survival time in patients with a form of brain tumor (oligodendroglioma) that carries a chromosomal abnormality called the 1p19q co-deletion.